Search by Drug Name or NDC
NDC 00093-5200-06 Buspirone Hydrochloride 30 mg/1 Details
Buspirone Hydrochloride 30 mg/1
Buspirone Hydrochloride is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Teva Pharmaceuticals USA, Inc.. The primary component is BUSPIRONE HYDROCHLORIDE.
MedlinePlus Drug Summary
Buspirone is used to treat anxiety disorders or in the short-term treatment of symptoms of anxiety. Buspirone is in a class of medications called anxiolytics. It works by changing the amounts of certain natural substances in the brain.
Related Packages: 00093-5200-06Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Buspirone
Product Information
| NDC | 00093-5200 |
|---|---|
| Product ID | 0093-5200_f2a05d58-ca70-4b89-aa19-6b63e85a57a5 |
| Associated GPIs | 57200005100340 |
| GCN Sequence Number | 044210 |
| GCN Sequence Number Description | buspirone HCl TABLET 30 MG ORAL |
| HIC3 | H2F |
| HIC3 Description | ANTI-ANXIETY DRUGS |
| GCN | 92121 |
| HICL Sequence Number | 001620 |
| HICL Sequence Number Description | BUSPIRONE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Buspirone Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Buspirone Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 30 |
| Active Ingredient Units | mg/1 |
| Substance Name | BUSPIRONE HYDROCHLORIDE |
| Labeler Name | Teva Pharmaceuticals USA, Inc. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA075022 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00093-5200-06 (00093520006)
| NDC Package Code | 0093-5200-06 |
|---|---|
| Billing NDC | 00093520006 |
| Package | 60 TABLET in 1 BOTTLE (0093-5200-06) |
| Marketing Start Date | 2004-03-26 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.12498 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | BUSPIRONE HCL 30 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis